Daily evaluation of circulating granulocyte-monocyte progenitors during bone marrow recovery from induction therapy in acute leukemia

Leuk Res. 1986;10(3):353-6. doi: 10.1016/0145-2126(86)90033-0.

Abstract

The notable increase of the circulating granulocyte-monocyte progenitors (PB CFU-GM) during bone marrow recovery following chemotherapy is a well known phenomenon. It has led to consider harvesting a large number of autologous stem cells by cytapheresis. Daily assessments have been conducted on the PB CFU-GM level in 9 patients with acute leukemia at the time of bone marrow regeneration after the first induction course in order to identify the circumstances of this rise. The PB CFU-GM maximum peak, of an average of 2142/ml, occurs between day 17 and day 23 after the chemotherapy has ended. A ten-fold increase of the PB CFU-GM level above normal values is maintained between 2 and 10 days. The PB CFU-GM peak coincides with that of the circulating immature myeloid cells and monocytes. The platelet rise above 100 X 10(9)/1 always occurs 2-7 days before the PB CFU-GM peak.

MeSH terms

  • Acute Disease
  • Adolescent
  • Adult
  • Blood Cell Count
  • Granulocytes*
  • Hematopoietic Stem Cells*
  • Humans
  • Leukemia / blood*
  • Leukemia / drug therapy
  • Male
  • Middle Aged
  • Monocytes*